Skip to main content

Advertisement

SpringerLink
Log in

Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose–response study

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Ketamine is an N-methyl-d-aspartate (NMDA) receptor antagonist that has medical indications but is also used as a recreational drug. Previous research has found persisting cognitive and psychotogenic effects of ketamine in chronic abusers of this drug 3 days after an acute dose.

Objective

The present study aimed to investigate the effects of ketamine on two processes related to drug abuse, response inhibition and reinforcement, and to examine whether an acute dose of ketamine produced residual cognitive effects in healthy volunteers.

Methods

Fifty-four healthy volunteers were given an 80-min infusion of one of two doses (0.4, 0.8 mg kg−1) of ketamine or placebo. Subjects completed a battery of tests at three time points: pre-infusion, during the infusion and 3 days later at follow-up. The battery consisted of tests of episodic and semantic memory, schizophrenic-like and dissociative symptoms, response inhibition and measures of subjective effects, including mood, bodily symptoms and enjoyment of and desire for the drug.

Results

Ketamine acutely impaired response inhibition and had related biphasic effects on the subjective reinforcing effects of the drug. Ketamine also acutely impaired episodic but not semantic memory and increased schizophrenic-like and dissociative symptoms. No residual cognitive effects were observed 3 days following an acute dose.

Conclusions

The lack of residual effects in healthy volunteers on day 3 indicates that impairments found on day 3 in ketamine abusers are chronic effects. The abuse of ketamine may be related to its capacity both to reinforce and to decrease response inhibition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abel KM, Allin MPG, Hemsley DR, Geyer MA (2003) Low dose ketamine increases pre-pulse inhibition in healthy men. Neuropharmacology 44:729–737

    Article  CAS  PubMed  Google Scholar 

  • Adler CM, Goldberg TE, Malhotra AK, Breier A (1998) Effects of ketamine on thought disorder, working memory and semantic memory in healthy volunteers. Biological Psychiatry 43:811–816

    Article  CAS  PubMed  Google Scholar 

  • Ahmed SN, Petchovsky L (1980) Abuse of ketamine. Br J Psychiatry 137:303

    CAS  Google Scholar 

  • Battig WF, Montague WE (1969) Category norms of verbal items in 56 categories. A replication and extension of the Connecticut category norms. J Exp Psychol 80:1–46

    Google Scholar 

  • Beck AT (1978) The Beck Depression Inventory (BDI). The Psychological Corporation. Harcourt Brace Jovanovitz Inc, USA

  • Bernstein E, Putnam FW (1986) Development, reliability and validity of a dissociation scale. J Nerv Ment Dis 174:727–735

    CAS  PubMed  Google Scholar 

  • Bond AJ, Lader MH (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218

    Google Scholar 

  • Bremner JD, Krystal JD, Putman FW, Southwick SM, Marmar C, Charney DS, Mazure CM (1998) Measurement of dissociative states with the Clinician Administered Dissociative States Scale (CADDS). J Traumatic Stress 11:125–136

    Article  CAS  Google Scholar 

  • Burgess P, Shallice T (1997) The Hayling and Brixton Tests. Thames Valley Test Company., Bury St. Edmunds, UK

  • Cornish JL, Duffy P, Kalivas PW (1993) A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behaviour. Neuroscience 93:1359–1367

    Article  Google Scholar 

  • Curran HV, Monaghan L (2001) In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 96:749–760

    Article  CAS  PubMed  Google Scholar 

  • Curran HV, Morgan CJA (2000) Cognitive, dissociative and psychotogenic effects of ketamine on recreational users on the night of drug use and 3 days later. Addiction 95:575–590

    CAS  PubMed  Google Scholar 

  • Di Chiara G (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375:13–30

    PubMed  Google Scholar 

  • Ellison G (1995) The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilipine as both behavioural and anatomical models of the dementias. Brain Res Rev 20:250–267

    CAS  PubMed  Google Scholar 

  • Finn PR, Justus A, Mazas C, Steinmetz JE (1999) Working memory, executive processes and the effects of alcohol on Go/No-Go learning: testing a model of behavioral regulation and impulsivity. Psychopharmacology 146:465–472

    Google Scholar 

  • Giancola PR (2000) Executive function: a conceptual framework for alcohol related aggression. Exp Clin Psychopharmacol 8:576–597

    Article  CAS  PubMed  Google Scholar 

  • Giancola PR, Moss HB, Martin CB, Kirisci L, Tarter RE (1996) Executive cognitive functioning predicts reactive aggression in boys at high risk for substance abuse: a prospective study. Alcohol Clin Exp Res 20:740–744

    CAS  PubMed  Google Scholar 

  • Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642–1652

    Article  PubMed  Google Scholar 

  • Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642–1652

    Article  PubMed  Google Scholar 

  • Grinspoon L, Bakalar JB (1997) Psychedelic drugs reconsidered. Basic Books, New York

  • Harborne GC, Watson FL, Healy DT, Groves L (1996) The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers. J Psychopharmacol 10:134–140

    CAS  Google Scholar 

  • Harris EW, Ganong AH, Cotman CW (1984) Long term potentiation in the hippocampus involves activation of N-methyl-d-aspartate receptors. Brain Res 323:132–137

    Article  CAS  PubMed  Google Scholar 

  • Hetem LAB, Danion JM, Diemunsch P, Brandt C (2000) Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology 152:283–288

    PubMed  Google Scholar 

  • Hewitt DJ (2000) The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain 16:S73–S79

    Article  CAS  PubMed  Google Scholar 

  • Higgins GA, Ballard TM, Huwyler J, Kemp JA, Gill R (2003) Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition. Neuropharmacology 44:324–341

    Article  CAS  PubMed  Google Scholar 

  • Hurt PH, Ritchie EC (1994) A case of ketamine dependence. Am J Psychiatry 151:779

    CAS  Google Scholar 

  • Jansen KLR (1990) Ketamine: can chronic use impair memory? Int J Addict 25:133–139

    CAS  Google Scholar 

  • Jansen KLR (2001) Ketamine: dreams and realities. Multidisciplinary association for psychedelic studies (MAPS), Sarasota, USA

  • Javitt D, Zukin S (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301–1308

    CAS  PubMed  Google Scholar 

  • Kamaya H, Krishna PR (1987) Ketamine addiction. Anaesthesiology 67:861–862

    CAS  Google Scholar 

  • Kirk JM, Doty P, de Wit H (1998) Effects of expectancies on subjective responses to oral delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav 59:287–293

    CAS  PubMed  Google Scholar 

  • Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS (1994) Subanesthetic effects of the non-competitive NMDA-antagonist, ketamine, in humans. Arch Gen Psychiatry 51:199–214

    CAS  PubMed  Google Scholar 

  • Krystal JH, Karper LP, Bennett A, D’Souza DC, Abi-Dargham A, Morrisey K, Charney DS (1998a) Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology 135:213–299

    Article  CAS  PubMed  Google Scholar 

  • Krystal JH, Petrakis IL, Webb E, Cooney NL, Karper LP, Namanworth S, Stetson P, Trevisan LA, Charney DS (1998b) Dose-related ethanol–like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry 55:354–360

    PubMed  Google Scholar 

  • Krystal JH, D’Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab D, Cassello K, Bowers MB, Vegso S, Heninger GR, Charney DS (1999) Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology 145:193–204

    Google Scholar 

  • Krystal JH, Bennett A, Abi-Saab D, Belger A, Karper LP, D’Souza DC, Lipschitz D, Abi-Dargham A, Charney DS (2000) Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biol Psychiatry 47:137–143

    CAS  PubMed  Google Scholar 

  • Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995a) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6:869–872

    CAS  PubMed  Google Scholar 

  • Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995b) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9–19

    Article  CAS  PubMed  Google Scholar 

  • Layer RT, Kaddis FG, Wallace L (1993) The NMDA-receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol Biochem Behav 44:245–247

    CAS  PubMed  Google Scholar 

  • Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14:301–307

    CAS  PubMed  Google Scholar 

  • Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A (1997) Ketamine induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17:141–150

    CAS  PubMed  Google Scholar 

  • Marquis KL, Webb MG, Moreton JE (1989) Effects of fixed ratio size and dose on phencyclidine self-administration by rats. Psychopharmacology 97:179–182

    Google Scholar 

  • Mixmag (2001) The Mixmag drug survey 2000: the world’s biggest drug survey. Mixmag, 84–103. London, UK, Emap

    Google Scholar 

  • Mixmag (2002) The Mixmag drug survey 2001: the world’s biggest drug survey. Mixmag, 84–103. London, UK, Emap

    Google Scholar 

  • Moretti R, Hassan SZ, Goodman LI, Meltzer HY (1984) Comparison of ketamine and thiopental in healthy volunteers: effect on mental status, mood and personality. Anesth Analg 63:1087–1096

    CAS  PubMed  Google Scholar 

  • Morgan CJA, Mofeez A, Brandner B, Bromley L, Curran HV (2003) Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology (in press)

  • Newcomer JW, Krystal JH (2001) NMDA Receptor regulation of memory and behaviour in humans. Hippocampus 11:529–542

    Article  CAS  PubMed  Google Scholar 

  • Newcomer JW, Farber NB, Jevtovic–Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW (1999) Ketamine-Induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20:106–118

    CAS  PubMed  Google Scholar 

  • Olney J, Labruyere J, Wang G, Wozniak D, Price MT, Sesma M (1991) NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254:1515–1518

    CAS  PubMed  Google Scholar 

  • Siegel RK (1978) Phencyclidine and ketamine intoxication: a study of recreational users. In: Peterson RC, Stillman R (eds) Phencyclidine abuse: an appraisal. National Institute on Drug Abuse Research Monograph. NIDA, Rockville, Maryland, pp 119–140

  • Smith GS, Schloesser R, Brodie JD, Dewey SL, Logan J, Vitkun SA, Simokowitz P, Hurley A, Cooper T, Volkow ND, Cancro R (1998) Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C raclopride in normal human subjects. Neuropsychopharmacology 18:18–25

    Google Scholar 

  • Spielberger C (1983) State-trait anxiety inventory (form Y). Palo Alto, California, Mind Garden. Ref Type: Pamphlet

    Google Scholar 

  • Weingartner H (2000) Metaphors and models of executive functioning: comment on Giancola. Exp Clin Psychopharmacol 8:609–611

    Article  CAS  PubMed  Google Scholar 

  • Wilson B, Cockburn J, Baddeley A (1985) The Rivermead behavioural memory test. Thames Valley Test Company, Bury St. Edmunds, UK

  • Winger G, Palmer RK, Woods J-H (1989) Drug-reinforced responding: rapid determination of dose-response functions. Drug Alcohol Depend 24:135–142

    CAS  PubMed  Google Scholar 

  • Zukin SR, Zukin RS (1979) Specific [3H]phencyclidine binding in rat central nervous system. Proc Natl Acad Sci U S A 76:5372–5376

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

C.J.A.M. was supported by a Medical Research Council (UK) studentship. This study was aided by a grant to H.V.C. from the University of London UK Central Research Fund.

Author information

Authors and Affiliations

  1. Clinical Psychopharmacology Unit, Sub-Department of Clinical Health Psychology, University College London, Gower St, London, WC1E 6BT, UK

    Celia J. A. Morgan & H. Valerie Curran

  2. UCL Centre for Anaesthesia, University College London Hospital, London, UK

    Ali Mofeez, Brigita Brandner & Lesley Bromley

Authors
  1. Celia J. A. Morgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali Mofeez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brigita Brandner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lesley Bromley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Valerie Curran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Celia J. A. Morgan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morgan, C.J.A., Mofeez, A., Brandner, B. et al. Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose–response study. Psychopharmacology 172, 298–308 (2004). https://doi.org/10.1007/s00213-003-1656-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1656-y

Keywords

Search

Navigation